Fig. 1From: In silico prediction of bioequivalence of atorvastatin tablets based on GastroPlus™ softwareSimulated and observed plasma concentration-time profiles (a, 20 mg; b, 40 mg atorvastatin) and parameter sensitivity analysis on Cmax(c-d) and AUC0 − t(e-f)Back to article page